Forced degradation study of strontium ranelate (Anti-osteoporetic drug)

International Journal of Pharmaceutical Sciences Review and Research

Volumn 12, Issue 2, 2012, Pages 22-26

  Swami, Ashwini S ^a   Pishawikar, Sachin A ^a   More, Harinath N ^a  

^a BHARATI VIDYAPEETH COLLEGE OF PHARMACY   (India)

Author keywords

Forced degradation; Ich guidelines; Osteoporosis; Strontium ranelate

Indexed keywords

HYDROGEN PEROXIDE; STRONTIUM RANELATE;

ACCURACY; ACIDITY; ALKALINITY; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG OXIDATION; DRUG PURITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOTODEGRADATION; TEMPERATURE SENSITIVITY;

EID: 84856860885     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tandon VR, Sharma S, Mahajan A, Parihar A, Singh K, Strontium Ranelate. Drug Review (JK Science), 8 (2), 2006, 114-115.
2. Durie BG, Katz M, Crowley J, Osteonecrosis of the jaw and bisphosphonates, N. Engl. J. Med. 353 (1), 2005, 99-102.
3. Sharma S, Tandon VR, Mahajan A, Therapeutic strategies for postmenopausal osteoporosis: Present and future, Obs and Gynae Today, 9 (11), 2004, 758-62.
4. Burlet N, Reginster JY, Strontium Ranelate: The First Dual Acting Treatment for Postmenopausal Osteoporosis, Clin Orthop Relat Res, 443, 2006, 55-60.
5. Dimai HP, Strontium ranelate: a novel concept for the treatment of osteoporosis. Wien Klin Wochenschr, 117(21-22), 2005, 728-38.
6. Marie PJ, Strontium ranelate: A physiological approach for optimizing bone formation and resorption, Bone, 38, 2006, S10-S14.
7. Ortolani S, Vai S, Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages. Bone, 38 (2), 2006, 19-22.
8. Mythili K, Gayatri S, Koya RT, Chitra K, Uma C, Reddy M. Development and validation of RP-HPLC method for the estimation of strontium ranelate in sachet, International Journal of Pharma and Bio Sciences, 2 (2), 2011, 258-263.
9. Reynolds DW, Facchine KL, Mullaney JF, Alsante KM, Hatajik TD, Motto MG, Available Guidance and Best Practices for Conducting Forced Degradation Studies. Pharmaceutical Technology, 2, 2002, 48-56.
10. Chopde VV, Sensitive Analytical Methods for Determination of Stability of Drugs in Pharmaceutical Dosage Forms, 2008. www.pharmainfo.net/reviews/ sensitive-analyticalmethods- determination-stability-drugs-pharmaceuticaldosage- forms.
11. ICH, Q1A (R2) Stability testing of new drug substances and products, International Conference on Harmonization, 2003.
12. ICH, Q1B Stability testing: Photostability testing of new drug substances and products, 1996.